IBOTENIC ACID Chemical Properties

Melting point:

141-147 °C

Density 

1.621±0.06 g/cm3 (20 ºC 760 Torr)

storage temp. 

Keep in dark place,Inert atmosphere,Room temperature

solubility 

H2O: soluble1mg/mL, clear, colorless (with sonication)

form 

White solid

pka

2.16±0.10(Predicted)

color 

white

Odor

Practically odorless. Faint, meat-like, mild and sweet taste in aqueous dilutions.

Water Solubility 

Soluble to 10 mM in water and to 100 mM in 1.1eq. NaOH

Stability:

Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20°C for up to 1 month.

InChIKey

IRJCBFDCFXCWGO-UHFFFAOYSA-N

LogP

-1.070 (est)

CAS DataBase Reference

2552-55-8(CAS DataBase Reference)

Safety Information

Hazard Codes 

T,Xn

Risk Statements 

23/24/25-25-40

Safety Statements 

45-38-36/37/39-28A-22-36

RIDADR 

1544

WGK Germany 

3

RTECS 

NY2100000

HazardClass 

6.1(b)

PackingGroup 

III

Toxicity

LD50 in mice, rats (mg/kg): 15, 42 i.v.; 38, 129 orally (Theobald)

MSDS

• Language:English Provider:ACROS

IBOTENIC ACID Usage And Synthesis

Description

Ibotenic acid (60573-88-8) is a conformationally restricted analog of glutamate which occurs naturally in Amanita mascaria and related mushrooms.? It is a non-specific glutamate receptor (both NMDA and mGluR) agonist.1 May be used to induce hippocampal lesioning in rat neurodegeneration models.2,3 Induces lesions in the subiculum in a mouse model of Alzheimer’s disease.4

Chemical Properties

Crystalline solid; forms monohydrate; mp151°C (303.8°F) (anhydrous), 145°C (293°F)(monohydrate); soluble in water and alcohol.

Uses

Ibotenic acid has been used to perform surgery in adult male zebra finches (Taeniopygia guttata) to study reversing reinforcement-induced vocal changes.

Uses

Ibotenic acid is a neuroexcitatory amino acid originally isolated from Amanita species that functions as a NMDA and metabotropic glutamate receptor agonist. As a neurotoxin, ibotenic acid is often used to induce brain lesions in animals that model cognitive dysfunctions resulting from neurodegenerative diseases, traumatic brain injury, and stroke.

Uses

Neurobiological tool.

Preparation

Isolated from the Japanese fly mushroom. The acid can be produced synthetically.

Definition

A isoxazole which, together with muscimol, is largely responsible for the toxicities of a number of mushrooms including those of the genus Amanita. It is a potent excitatory amino acid.

Hazard

Neurotoxic; causes motor depression, ataxia, changes in mood, perceptions and feelings.

Health Hazard

Ibotenic acid is a potent neurologic aminoacid. It exhibits neuroexcitatory activity andcauses sedative actions on spinal neurons.High doses can cause sleep, hallucinations,distorted perceptions, and nausea. In humansthe symptoms above may be manifested fromingestion of 6–8 mg of ibotenic acid.
LD50 value, oral (mice): 38 mg/kg
LD50 value, intraperitoneal (mice): 15 mg/kg.

Biological Activity

NMDA and metabotropic glutamate receptor agonist.

Biochem/physiol Actions

Non-selective agonist with preference for NMDA glutamate receptors; neurotoxin; neuroexcitatory amino acid originally isolated from Amanita species.

storage

-20°C (desiccate)

Purification Methods

It has been converted to the ammonium salt (m 121-123o dec) dissolved in H2O, passed through an Amberlite IR 120 resin (H+ form) and eluted with H2O. The acidic fractions are collected, evaporated to dryness and the residue recrystallises from H2O as the monohydrate (m 144-146o). The anhydrous acid is obtained by making a slurry with MeOH, decanting and evaporating to dryness, and repeating the process twice more to give the anhydrous acid (m 151-152o). Recrystallisation from H2O gives the monohydrate. [Nakamura Chem Pharm Bull Jpn 19 46 1971.] The ethyl ester forms needles when crystallised from a small volume of Et2O and has m 78-79o and IR (CHCl3) with max 35002300 (OH), 1742 (ester C=O), 1628, 1528cm-1, and UV with λmax (EtOH) at 206nm (ε 7,080). The hydrazide has m 174-175o (from MeOH) with IR (KBr) 1656 (C=O)cm-1.

References

1) Nakanishi (1992), Molecular diversity of glutamate receptors and implications for brain function; Science 258 597 2) Jarrard (1989), On the use of ibotenic acid to lesion selectively different components of the hippocampal formation; J. Neurosci. Methods 29 251 3) Isacson and Peschanski (1992), Is there capacity for anatomical and functional repair in the adult somatosensory thalamus?; Exp. Neurol. 115 173 4) George et al. (2014), Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer’s disease; Acta Neuropathol. Commun. 2 17

IBOTENIC ACID(2552-55-8)Related Product Information

• 4-Phosphonophenylglycine
• AIDA
• L-AP4
• L-AP3
• (+-)-2-AMINO-3-PHOSPHONOPROPIONIC ACID ( AP-3)NMDA ANTAGONIST
• JNJ 16259685
• CPPG
• (2R,4R)-APDC
• MPPG
• IBOTENIC ACID
• IBOTENIC ACID MONOHYDRATE
• L-Ibotenic acid
• (R)-4-BROMO-HOMO-IBOTENIC ACID, >98%,(R)-4-BROMO-HOMO-IBOTENIC ACID
• (S)-4-BROMO-HOMO-IBOTENIC ACID, >98%,(S)-4-BROMO-HOMO-IBOTENIC ACID
• (RS)-4-BROMO-HOMO-IBOTENIC ACID
• TRICHOLOMIC ACID = DIHYDRO-IBOTENIC ACID
• IBOTENIC ACID UN2811 (III)
• IBOTENIC ACID(REAGENT / STANDARD GRADE)